Published on : Aug 10, 2017
Albany, New York, August 10, 2017: Wet Macular Degeneration is one of the most traumatic and damaging conditions that affects people. It is a disease, which has many risk factors. A new study, providing detailed market insights finds that the market for macular degeneration therapeutics is driven by the number of macular degeneration patients across the globe. The study is titled as “Wet Macular Degeneration-Market Insights, Epidemiology and Market Forecast-2025” and now has been broadcasted to the vast repository of Market Research Hub (MRH). This forecast report provides an overview of the disease and in depth research related to Wet Macular Degeneration for seven major markets, including United States, Germany, Japan, France, Italy, Spain and UK for the study period undertaken from 2015-2025.
Macular degeneration is a weakening or collapsed working of the eyes’ macula. There are two types of macular degeneration namely wet and dry macular degeneration. Wet macular degeneration is a beginning of abnormal growth of blood vessels underneath the retina, these overgrown blood vessels leak blood which hampers clarity of central vision leading to macular degeneration. The prevalence of people living with wet macular degeneration is less as compared to dry form, but it causes more damage to central or detail vision.
In the last couple of years, many companies have invested heavily in research and development of drugs on wet macular degeneration such as Allergan completed Stage 3, Phase 2 study of Abicipar Pegol. It has been analyzed that increasing awareness of MD and increasing pipeline products of AMD and higher drug treatment rate is supporting the growth of the macular degeneration market. The most successful method of treating Wet AMD is the administration of ANTI-VEGF drugs. The primary one used for wet macular degeneration treatment is Lutein. Lutein is a very powerful substance found in macula.
Moving further, a detailed outlook and understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for wet macular generation is highlighted. The increasing number of old age population all over the world is creating more demand for treatment. As per the analyst findings, the forecasted patient population having wet macular generation for the year 2025 will grow, expanding at an impressive CAGR from 2015 to 2025 and the wet macular degeneration 7MM market size is estimated to reach a maximum value within the same period.
Through the geographical analysis, this study enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of wet macular degeneration for 7 major markets. Additionally, market size from the period 2015 to 2025, and estimated market trends are presented in detail.
Request a Sample with TOC in a PDF format : http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265944
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : email@example.com